Literature DB >> 4418174

Soluble membrane antigens of human malignant melanoma cells.

A C Hollinshead, R B Herberman, W J Jaffurs, L K Alpert, J P Minton, J E Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4418174     DOI： 10.1002/1097-0142(197410)34:4<1235::aid-cncr2820340433>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  7 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

2.  Thymus-derived lymphocyte enumeration in patients with uveal malignant melanoma.

Authors:  N T Felberg; J A Shields
Journal:  Br J Ophthalmol       Date:  1984-07       Impact factor: 4.638

Review 3.  Human tumor-associated antigens identified by monoclonal antibodies.

Authors:  K E Hellström; I Hellström; J P Brown
Journal:  Springer Semin Immunopathol       Date:  1982

4.  Monoclonal antibodies in detection of choroidal melanoma.

Authors:  P J Ringens; R van Haperen; C Vennegoor; P T de Jong; S G van Duinen; D J Ruiter; A W van der Kamp
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Human malignant melanoma antigenic properties of phenol water extracts.

Authors:  L Suter; H Tilkorn; P M Kövary
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

6.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

7.  Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.

Authors:  J H Marti; D M Thomson
Journal:  Br J Cancer       Date:  1976-08       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.